Trial | NCT03039504  Report issue

Official Title

Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    potensa ...

  • Study Participants

    106
This is a randomized, double blind, placebo-controlled, comparative, prospective study (clinical evaluation) of the effectiveness and safety of dietary supplement Potensa in men with mild to moderate erectile dysfunction.
Study Started
Jan 31
2017
Primary Completion
Jun 28
2017
Study Completion
Jun 28
2017
Last Update
Jul 02
2017

Dietary Supplement Potensa, a succinate-based dietary supplement

Potensa - a dietary supplement: 4 capsules (2 white 200mg each and 2 blue 200 mg each) once a day with a meal or immediately after a meal, preferably after breakfast, for 3 months.

Dietary Supplement Placebo

Placebo: 4 capsules (2 white 200mg each and 2 blue 200 mg each) once a day with a meal or immediately after a meal, preferably after breakfast, for 3 months.

Potensa Experimental

succinate-based dietary supplement

Placebo Placebo Comparator

placebo

Criteria 

Inclusion Criteria:

Men, 18 years of age or older;
Patients diagnosed with "erectile dysfunctions" of various pathogenesis, typical form without complications;
Ability to read and understand informed consent in order to participate in the study;
Ability to follow study's conditions.

Exclusion Criteria:

Oncological illnesses, except those in complete remission for at least 5 years;
Conditions that may require emergency or planned hospitalization in the next 6 months;
Extragenital endocrine conditions (hormonally active) (thyroid, adrenal glands, pituitary, hypothalamus);
Surgeries on sex organ within 1 year of the screening;
Any surgeries within 3 months of the screening;
Psychiatric illnesses;
Diabetes mellitus;
Cryptorchidism
Taking other dietary supplements that can affect erectile dysfunction within 1 month of participating in the study;
High risk of non-compliance.
No Results Posted